ReShape Lifesciences Inc. (NASDAQ: RSLS)
$5.8200
+0.2400 ( +2.65% ) 16.0K
Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus.
Market Data
Open
$5.8200
Previous close
$5.5800
Volume
16.0K
Market cap
$4.10M
Day range
$5.5150 - $5.9100
52 week range
$4.6000 - $34.2200
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
10-q | Quarterly Reports | 63 | Nov 14, 2024 |
8-k | 8K-related | 16 | Nov 14, 2024 |
8-k | 8K-related | 20 | Oct 17, 2024 |
8-k | 8K-related | 17 | Sep 24, 2024 |
8-k | 8K-related | 16 | Aug 14, 2024 |
10-q | Quarterly Reports | 62 | Aug 14, 2024 |
4 | Insider transactions | 1 | Aug 13, 2024 |
8-k | 8K-related | 21 | Jul 09, 2024 |
8-k | 8K-related | 16 | May 20, 2024 |
10-q | Quarterly Reports | 60 | May 15, 2024 |